Gts Securities LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$28.84 - $41.15 $204,764 - $292,165
7,100 New
7,100 $204,000
Q4 2023

Feb 14, 2024
SELL
$37.14 - $64.82 $2.93 Million - $5.11 Million
-78,900 Reduced 40.15%
117,600 $7.04 Million
Q3 2023

Nov 15, 2023
BUY
$23.65 - $89.22 $4.65 Million - $17.5 Million
196,500 New
196,500 $7.47 Million

Others Institutions Holding APLS

# of Institutions
309
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.79B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email